CRISPR Therapeutics AG
2017 Q1 - 2025 Q4 (36 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 122 | 0.0% | 2,323 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 146 | 0.0% | 2,254 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 101 | 0.0% | 2,072 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 62 | 0.0% | 1,822 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 73 | 0.0% | 1,863 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 46 | 0.0% | 981 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 56 | 0.0% | 1,038 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 70 | 0.0% | 1,031 | 3/31/2024 |
| 2023 Q4 | 8/15/2024 | 50 | 0.0% | 800 | 12/31/2023 |
| 2023 Q3 | 8/15/2024 | 41 | 0.0% | 901 | 9/30/2023 |
| 2023 Q2 | 8/15/2024 | 51 | 0.0% | 901 | 6/30/2023 |
| 2023 Q1 | 8/15/2024 | 43 | 0.0% | 943 | 3/31/2023 |
| 2022 Q4 | 8/15/2024 | 21 | 0.0% | 518 | 12/31/2022 |
| 2022 Q3 | 8/15/2024 | 55 | 0.0% | 843 | 9/30/2022 |
| 2022 Q2 | 8/15/2024 | 45 | 0.0% | 743 | 6/30/2022 |
| 2022 Q1 | 8/15/2024 | 52 | 0.0% | 828 | 3/31/2022 |
| 2021 Q4 | 8/30/2024 | 74 | 0.0% | 983 | 12/31/2021 |
| 2021 Q3 | 8/30/2024 | 116 | 0.0% | 1,038 | 9/30/2021 |
| 2021 Q2 | 8/30/2024 | 204 | 0.0% | 1,258 | 6/30/2021 |
| 2021 Q1 | 8/30/2024 | 157 | 0.0% | 1,289 | 3/31/2021 |
| 2020 Q4 | 8/30/2024 | 170 | 0.0% | 1,110 | 12/31/2020 |
| 2020 Q3 | 8/30/2024 | 84 | 0.0% | 1,003 | 9/30/2020 |
| 2020 Q2 | 8/30/2024 | 317 | 0.0% | 4,301 | 6/30/2020 |
| 2020 Q1 | 8/30/2024 | 1,074 | 0.0% | 25,038 | 3/31/2020 |
| 2019 Q4 | 8/30/2024 | 90 | 0.0% | 1,480 | 12/31/2019 |
| 2019 Q3 | 8/30/2024 | 64 | 0.0% | 1,570 | 9/30/2019 |
| 2019 Q2 | 8/30/2024 | 74 | 0.0% | 1,570 | 6/30/2019 |
| 2019 Q1 | 8/30/2024 | 57 | 0.0% | 1,600 | 3/31/2019 |
| 2018 Q4 | 8/30/2024 | 49 | 0.0% | 1,700 | 12/31/2018 |
| 2018 Q3 | 8/30/2024 | 192 | 0.0% | 4,330 | 9/30/2018 |
| 2018 Q2 | 8/30/2024 | 272 | 0.0% | 4,630 | 6/30/2018 |
| 2018 Q1 | 8/30/2024 | 50 | 0.0% | 1,100 | 3/31/2018 |
| 2017 Q4 | 8/30/2024 | 6 | 0.0% | 250 | 12/31/2017 |
| 2017 Q3 | 8/30/2024 | 4 | 0.0% | 250 | 9/30/2017 |
| 2017 Q2 | 8/30/2024 | 13 | 0.0% | 800 | 6/30/2017 |
| 2017 Q1 | 8/30/2024 | 14 | 0.0% | 648 | 3/31/2017 |